Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
posted on
Apr 12, 2021 05:15PM
Agreed, or at least multiple endpoints.
But then study would have to be longer.
Still worth knowing whether it helps patients during the time frame. Just wish it were designed to ask more than just that.